Annual Shareholders Equity
$29.45 M
+$120.63 M+132.30%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual stockholders equity is $29.45 million, with the most recent change of +$120.63 million (+132.30%) on December 31, 2021.
- During the last 3 years, IDRA annual shareholders equity has fallen by -$34.54 million (-53.98%).
Performance
IDRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$20.77 M
-$364.00 K-1.72%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly stockholders equity is $20.77 million, with the most recent change of -$364.00 thousand (-1.72%) on September 30, 2022.
- Over the past year, IDRA quarterly shareholders equity has dropped by -$12.24 million (-37.09%).
Performance
IDRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IDRA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +132.3% | -37.1% |
| 3 y3 years | -54.0% | -44.8% |
| 5 y5 years | -72.7% | -66.5% |
IDRA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -29.5% | at low |
| 5 y | 5-year | at high | -409.6% | -50.9% | -539.0% |
| alltime | all time | -72.7% | -409.6% | -81.7% | -539.0% |
Idera Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $20.77 M(-1.7%) |
| Jun 2022 | - | $21.13 M(-18.2%) |
| Mar 2022 | - | $25.84 M(-12.3%) |
| Dec 2021 | $29.45 M(-132.3%) | $29.45 M(-10.8%) |
| Sep 2021 | - | $33.01 M(-12.5%) |
| Jun 2021 | - | $37.73 M(-10.8%) |
| Mar 2021 | - | $42.30 M(-146.4%) |
| Dec 2020 | -$91.17 M(+716.4%) | -$91.17 M(+181.1%) |
| Sep 2020 | - | -$32.44 M(+83.3%) |
| Jun 2020 | - | -$17.69 M(>+9900.0%) |
| Mar 2020 | - | -$144.00 K(-98.7%) |
| Dec 2019 | -$11.17 M(-117.5%) | -$11.17 M(-129.7%) |
| Sep 2019 | - | $37.63 M(-21.2%) |
| Jun 2019 | - | $47.73 M(-14.3%) |
| Mar 2019 | - | $55.67 M(-13.0%) |
| Dec 2018 | $63.99 M(-40.6%) | $63.99 M(-14.5%) |
| Sep 2018 | - | $74.87 M(-12.0%) |
| Jun 2018 | - | $85.07 M(-14.0%) |
| Mar 2018 | - | $98.88 M(-8.2%) |
| Dec 2017 | $107.69 M(+4.2%) | $107.69 M(+73.5%) |
| Sep 2017 | - | $62.08 M(-17.1%) |
| Jun 2017 | - | $74.87 M(-17.0%) |
| Mar 2017 | - | $90.19 M(-12.7%) |
| Dec 2016 | $103.35 M(+23.6%) | $103.35 M(+107.2%) |
| Sep 2016 | - | $49.87 M(-18.3%) |
| Jun 2016 | - | $61.05 M(-16.0%) |
| Mar 2016 | - | $72.68 M(-13.0%) |
| Dec 2015 | $83.58 M(+92.6%) | $83.58 M(-9.8%) |
| Sep 2015 | - | $92.66 M(-9.6%) |
| Jun 2015 | - | $102.51 M(-9.5%) |
| Mar 2015 | - | $113.27 M(+161.0%) |
| Dec 2014 | $43.40 M(+33.7%) | $43.40 M(-17.8%) |
| Sep 2014 | - | $52.82 M(-12.3%) |
| Jun 2014 | - | $60.26 M(-9.9%) |
| Mar 2014 | - | $66.88 M(+106.1%) |
| Dec 2013 | $32.45 M(+389.7%) | $32.45 M(-12.5%) |
| Sep 2013 | - | $37.11 M(+166.5%) |
| Jun 2013 | - | $13.93 M(+413.9%) |
| Mar 2013 | - | $2.71 M(-59.1%) |
| Dec 2012 | $6.63 M(-63.1%) | $6.63 M(-392.6%) |
| Sep 2012 | - | -$2.27 M(-210.1%) |
| Jun 2012 | - | $2.06 M(-63.1%) |
| Mar 2012 | - | $5.57 M(-69.0%) |
| Dec 2011 | $17.95 M(-45.8%) | $17.95 M(+7.8%) |
| Sep 2011 | - | $16.65 M(-22.5%) |
| Jun 2011 | - | $21.47 M(-20.3%) |
| Mar 2011 | - | $26.95 M(-18.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $33.10 M(-0.0%) | $33.10 M(-13.6%) |
| Sep 2010 | - | $38.33 M(+36.3%) |
| Jun 2010 | - | $28.11 M(-13.2%) |
| Mar 2010 | - | $32.41 M(-2.1%) |
| Dec 2009 | $33.10 M(+49.3%) | $33.10 M(+16.3%) |
| Sep 2009 | - | $28.45 M(+3.6%) |
| Jun 2009 | - | $27.47 M(+20.9%) |
| Mar 2009 | - | $22.73 M(+2.5%) |
| Dec 2008 | $22.17 M(+187.2%) | $22.17 M(+5.9%) |
| Sep 2008 | - | $20.94 M(+40.5%) |
| Jun 2008 | - | $14.91 M(+41.3%) |
| Mar 2008 | - | $10.55 M(+36.6%) |
| Dec 2007 | $7.72 M(-36.9%) | $7.72 M(-25.5%) |
| Sep 2007 | - | $10.36 M(-18.5%) |
| Jun 2007 | - | $12.72 M(-15.8%) |
| Mar 2007 | - | $15.11 M(+23.5%) |
| Dec 2006 | $12.24 M(-3747.4%) | $12.24 M(+5094.0%) |
| Sep 2006 | - | $235.60 K(-25.5%) |
| Jun 2006 | - | $316.10 K(-92.9%) |
| Mar 2006 | - | $4.47 M(-1431.4%) |
| Dec 2005 | -$335.50 K(-102.6%) | -$335.50 K(-109.7%) |
| Sep 2005 | - | $3.44 M(-44.9%) |
| Jun 2005 | - | $6.24 M(-35.5%) |
| Mar 2005 | - | $9.68 M(-24.2%) |
| Dec 2004 | $12.77 M(+21.3%) | $12.77 M(-18.7%) |
| Sep 2004 | - | $15.71 M(+5.1%) |
| Jun 2004 | - | $14.94 M(+95.5%) |
| Mar 2004 | - | $7.64 M(-27.4%) |
| Dec 2003 | $10.53 M(-39.7%) | $10.53 M(-29.1%) |
| Sep 2003 | - | $14.84 M(+200.5%) |
| Jun 2003 | - | $4.94 M(-44.0%) |
| Mar 2003 | - | $8.82 M(-49.4%) |
| Dec 2002 | $17.44 M(<-9900.0%) | $17.44 M(-15.9%) |
| Sep 2002 | - | $20.73 M(-1481.6%) |
| Jun 2002 | - | -$1.50 M(+46.7%) |
| Mar 2002 | - | -$1.02 M(+2970.9%) |
| Dec 2001 | -$33.30 K(-99.6%) | -$33.30 K(-103.4%) |
| Sep 2001 | - | $990.00 K(-44.1%) |
| Jun 2001 | - | $1.77 M(-158.2%) |
| Mar 2001 | - | -$3.04 M(-59.6%) |
| Dec 2000 | -$7.53 M(+23.4%) | -$7.53 M(+18.1%) |
| Sep 2000 | - | -$6.38 M(-41.4%) |
| Jun 2000 | - | -$10.89 M(+28.0%) |
| Mar 2000 | - | -$8.50 M |
| Dec 1999 | -$6.10 M(-371.3%) | - |
| Dec 1998 | $2.25 M(-104.9%) | - |
| Dec 1997 | -$46.05 M(-301.5%) | - |
| Dec 1996 | $22.85 M | - |
FAQ
- What is Idera Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual shareholders equity year-on-year change?
- What is Idera Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Idera Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of IDRA is $29.45 M
What is the all time high annual shareholders equity for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual stockholders equity is $107.69 M
What is Idera Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, IDRA annual stockholders equity has changed by +$120.63 M (+132.30%)
What is Idera Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of IDRA is $20.77 M
What is the all time high quarterly shareholders equity for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly stockholders equity is $113.27 M
What is Idera Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, IDRA quarterly stockholders equity has changed by -$12.24 M (-37.09%)